Company invites individual and institutional investors, as well as advisors and analysts, to attend online at ...

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced ...